Format:
XIII, 494 S.
,
graph. Darst.
ISBN:
9780470343425
Note:
Includes bibliographical references and index
,
Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan WangCentral glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemias associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current antidiabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang.
,
Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism
,
Central glucose sensing and control of food intake and energy homeostasis
,
Abnormalities in insulin secretion in type 2 diabetes mellitus
,
Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae
,
Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis
,
Energy metabolism in skeletal muscle and its link to insulin resistance
,
Mechanisms and complications of metabolic syndrome
,
Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL
,
Mechanism of action of niacin : implications for atherosclerosis and drug discovery
,
Current anti-diabetic therapies and mechanisms
,
GLP-1 biology, signaling mechanisms, physiology, and clinical studies
,
Dipeptidyl peptidase IV inhibitors for treatment of diabetes
,
Sodium glucose co-transporter 2 inhibitors
,
Fibroblast growth factor 21 as a novel metabolic regulator
,
Sirtuins as potential drug targets for metabolic diseases
,
11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes
,
Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade
,
Drug development for metabolic diseases: past, present and future
Language:
English
Keywords:
Metabolisches Syndrom
